Cite Filings / VERA / 0000902664-25-000985
Feed Companies Filings Check
Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Vera Therapeutics, Inc. · Filed 2025-02-14 · Acc 0000902664-25-000985

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-02-20 4 Chief Development Officer acquired 22,500 shares (grant or award)
  • 2025-02-20 4 Chief Medical Officer acquired 26,900 shares (grant or award)
  • 2025-02-20 4 CHIEF FINANCIAL OFFICER acquired 26,900 shares (grant or award)
  • 2025-02-20 4 PRESIDENT AND CEO acquired 80,750 shares (grant or award)
  • 2025-02-20 4 Chief Operating Officer acquired 26,900 shares (grant or award)
  • 2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 9.71%
  2. 2026-11-16 SCHEDULE 13G/A · Avoro Capital Advisors LLC 7.82%
  3. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 3.8%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…